ACTRN12619000160134
Recruiting
未知
Retrospective validation of a risk stratification tool developed for management of patients with blunt chest trauma.
Saptarshi Mukerji0 sites500 target enrollmentFebruary 4, 2019
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- trauma
- Sponsor
- Saptarshi Mukerji
- Enrollment
- 500
- Status
- Recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Male or Female, aged 18 years or above. No upper age limit has been set.
- •Patients who have presented with a primary diagnosis of blunt chest trauma.
Exclusion Criteria
- •Patients with penetrating chest trauma
- •Patients presenting with any immediate life\-threatening injuries
- •Patients with multi\-trauma defined as any concurrent injuries, in addition to chest trauma, that will significantly determine the patient’s management
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Validation study of the recurrence risk stratification using 55-gene classifier (55GC) and RAS mutation in StageII/III colon cancerColon CancerJPRN-UMIN000023879ational Defense Medical College and Kyushu University1,000
Completed
Phase 2
Risk Stratification Procedure for Thromboembolism ProphylaxisTotal Knee Replacement SurgeriesNCT04031859Ministry of Health, Saudi Arabia242
Completed
Not Applicable
Practical risk stratification score for prediction of contrast-induced nephropathy after primary percutaneous coronary intervention in patients with acute ST segment elevation myocardial infarction: development and internal validatioContrast-induced nephropathy was defined as the deterioration of renal function following the administration of contrast agents and unlikely to be explained by other possible causes. Patients with anprediction score,contrast-induced nephropathy,STEMITCTR20190705001/A217
Recruiting
Not Applicable
Prediction of cancer-associated venous thromboembolismCancer-associated venous thromboembolismNL-OMON23071Amsterdam UMC2,000
Completed
Not Applicable
Risk model to predict adverse outcomes after primary percutaneous coronary intervention (PCI)ISRCTN83474650Clinical Center of Serbia (Serbia)1,750